{
  "data": {
    "id": "stat_WZQGKCJ44HNCBQ89JGQ0HBW2D2",
    "url": "https://statorigin.org/stat/stat_WZQGKCJ44HNCBQ89JGQ0HBW2D2",
    "indicator": {
      "slug": "innovative-drug-approvals-half-year",
      "name": "Innovative drug approvals (half year)",
      "definition": "Total number of innovative pharmaceutical products granted regulatory marketing authorization."
    },
    "industry": [
      {
        "slug": "pharmaceuticals",
        "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
        "isic": "C21",
        "is_primary": true
      }
    ],
    "region": {
      "code": "CN",
      "name": "China",
      "type": "country"
    },
    "period": {
      "start": "2026-01-01",
      "end": "2026-06-30",
      "type": "point"
    },
    "value": 38,
    "value_text": "38",
    "unit": "count",
    "currency": null,
    "scale": "1",
    "value_type": "actual",
    "source": {
      "org": "State Council of China",
      "org_short_name": "State Council",
      "org_url": "https://www.gov.cn",
      "org_tier": 1,
      "document_title": "Value of China's innovative drug out-licensing deals hit new high in H1",
      "document_url": "https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html",
      "document_type": "press_release",
      "locator": "Value of China's innovative drug out-licensing deals hit new high in H1",
      "quote": "China approved 38 innovative drugs for marketing during the period, including 31 developed by domestic companies, Tao Qing, head of the bureau for operation, monitoring and coordination with the MIIT, told a media conference.",
      "published_date": null,
      "accessed_at": "2026-09-17",
      "license": "see-source",
      "url_status": "ok"
    },
    "verification": "verified",
    "verified_by": "seed:auto-extract-v1",
    "verified_at": "2026-09-17T07:16:01.811Z",
    "confidence": 0.9,
    "is_secondhand": false,
    "supersedes": null,
    "superseded_by": null,
    "is_current": true,
    "citation": {
      "apa": "State Council of China. (2026). Value of China's innovative drug out-licensing deals hit new high in H1. Retrieved September 17, 2026, from https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Via StatOrigin, https://statorigin.org/stat/stat_WZQGKCJ44HNCBQ89JGQ0HBW2D2",
      "bibtex": "@misc{statecouncil2026innovativehbw2d2,\n  author       = {{State Council of China}},\n  title        = {Value of China's innovative drug out-licensing deals hit new high in H1},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_WZQGKCJ44HNCBQ89JGQ0HBW2D2},\n  note         = {Original source: https://english.www.gov.cn/archive/statistics/202607/20/content\\_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026.}\n}"
    },
    "updated_at": "2026-09-17T07:16:01.811Z",
    "contested_by": [],
    "related": []
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}